Cargando…
Analysis of tumor environmental response and oncogenic pathway activation identifies distinct basal and luminal features in HER2-related breast tumor subtypes
INTRODUCTION: Breast cancer heterogeneity occurs as a consequence of the dysregulation of numerous oncogenic pathways as well as many non-genetic factors, including tumor microenvironmental stresses such as hypoxia, lactic acidosis, and glucose deprivation. Although the importance of these non-genet...
Autores principales: | Gatza, Michael L, Kung, Hsiu-Ni, Blackwell, Kimberly L, Dewhirst, Mark W, Marks, Jeffrey R, Chi, Jen-Tsan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218951/ https://www.ncbi.nlm.nih.gov/pubmed/21672245 http://dx.doi.org/10.1186/bcr2899 |
Ejemplares similares
-
The therapeutic response of ER+/HER2− breast cancers differs according to the molecular Basal or Luminal subtype
por: Bertucci, François, et al.
Publicado: (2020) -
Luminal A and luminal B (HER2 negative) subtypes of breast cancer consist of a mixture of tumors with different genotype
por: Yanagawa, Masumi, et al.
Publicado: (2012) -
An integrated genomics approach identifies drivers of proliferation in luminal subtype human breast cancer
por: Gatza, Michael L., et al.
Publicado: (2014) -
Luminal B breast tumors are not HER2 positive
por: Bhargava, Rohit, et al.
Publicado: (2008) -
EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2(+), basal-like, and HER2 intrinsic subtypes of breast cancer
por: Soysal, S D, et al.
Publicado: (2013)